Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
UCSF Seminar: "Dynamics of Retina Damage in Acute Optic Neuritis"
Rituximab product approval information - Licensing action
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.
Thrombotic microangiopathy associated with use of interferon-beta.
Interferon β for secondary progressive multiple sclerosis: a systematic review.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Focal vibration in neurorehabilitation.
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
Interferon beta for secondary progressive multiple sclerosis.
Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis.
Society for Neuroscience Annual Meeting
Inflammation-induced fatigue: Exploring neurobiological mechanisms and potential treatments
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy.
Zebrafish myelination: a transparent model for remyelination?
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.
Alemtuzumab benefits hard-to-treat MS patients
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
Alemtuzumab and multiple sclerosis: therapeutic application.
The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Pages
« first
‹ previous
…
102
103
104
105
106
107
108
109
110
…
next ›
last »